These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16270196)
1. Comment to: Grassi G, Dell'oro R, Quarti-Trevano F et al (2005) neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48:1359-1365. Clark MG Diabetologia; 2005 Dec; 48(12):2689-90. PubMed ID: 16270196 [No Abstract] [Full Text] [Related]
2. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Grassi G; Dell'Oro R; Quarti-Trevano F; Scopelliti F; Seravalle G; Paleari F; Gamba PL; Mancia G Diabetologia; 2005 Jul; 48(7):1359-65. PubMed ID: 15933859 [TBL] [Abstract][Full Text] [Related]
3. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome. Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752 [TBL] [Abstract][Full Text] [Related]
4. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome. Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393 [TBL] [Abstract][Full Text] [Related]
5. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia? Brun JF; Aloulou I; Varlet-Marie E Clin Hemorheol Microcirc; 2004; 30(3-4):203-9. PubMed ID: 15258344 [TBL] [Abstract][Full Text] [Related]
6. Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome. Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Richards K; Dixon JB; Schlaich MP; Lambert EA Metabolism; 2015 Jul; 64(7):797-803. PubMed ID: 25827058 [TBL] [Abstract][Full Text] [Related]
11. Beyond the body mass index: tracking body composition in the pathogenesis of obesity and the metabolic syndrome. Müller MJ; Lagerpusch M; Enderle J; Schautz B; Heller M; Bosy-Westphal A Obes Rev; 2012 Dec; 13 Suppl 2():6-13. PubMed ID: 23107255 [TBL] [Abstract][Full Text] [Related]
12. A Larger Body Mass Index is Associated with Increased Atherogenic Dyslipidemia, Insulin Resistance, and Low-Grade Inflammation in Individuals with Metabolic Syndrome. Ebron K; Andersen CJ; Aguilar D; Blesso CN; Barona J; Dugan CE; Jones JL; Al-Sarraj T; Fernandez ML Metab Syndr Relat Disord; 2015 Dec; 13(10):458-64. PubMed ID: 26431271 [TBL] [Abstract][Full Text] [Related]
13. Intermittent hypoxia and diet-induced obesity: effects on oxidative status, sympathetic tone, plasma glucose and insulin levels, and arterial pressure. Olea E; Agapito MT; Gallego-Martin T; Rocher A; Gomez-Niño A; Obeso A; Gonzalez C; Yubero S J Appl Physiol (1985); 2014 Oct; 117(7):706-19. PubMed ID: 25103975 [TBL] [Abstract][Full Text] [Related]
15. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents. Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896 [TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome--from insulin resistance to obesity and diabetes. Gallagher EJ; Leroith D; Karnieli E Med Clin North Am; 2011 Sep; 95(5):855-73. PubMed ID: 21855696 [TBL] [Abstract][Full Text] [Related]